Bolt Biotherapeutics

$23.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.99 (+9.06%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell BOLT and other stocks, options, and ETFs commission-free!

About BOLT

Bolt Biotherapeutics, Inc. Common Stock, also called Bolt Biotherapeutics, is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

CEO
Randall C. Schatzman
Employees
65
Headquarters
Redwood City, California
Founded
2015
Market Cap
942.95M
Price-Earnings Ratio
Dividend Yield
Average Volume
191.80K
High Today
$24.35
Low Today
$22.15
Open Price
$22.15
Volume
185.91K
52 Week High
$43.07
52 Week Low
$20.87

BOLT Earnings

-$14.58
-$9.72
-$4.86
$0.00
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 13, After Hours

You May Also Like

FREEW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure